Chemokine receptor CCR6-dependent accumulation of IL-17 producing gamma-delta T cells in injured liver restricts hepatic inflammation and fibrosis
Year: 2013
Type: dissertation
Abstract: Chronic liver injury promotes hepatic inflammation, representing a prerequisite for organ fibrosis, a common consequence of various liver diseases. In this study we investigated the contribution of the chemokine receptor CCR6 and its ligand CCL20 to chronic liver injury and hepatic fibrosis. CCR6 is known to be expressed on some T helper cells and gamma/delta T cells, monocyte derived dendritic cells and B cell subsets. It plays an important role in mucosal immunity and has been implicated in the migration of Th17, regulatory (Treg) and gamma/delta T cells, but its role in liver disease is largely unknown. Therefore we analyzed human liver samples of patients with chronic liver disease of various etiologies for expression of CCR6 and CCL20. Additionally, wildtype (wt) and CCR6 knock-out (Ccr6-/-) mice were treated with the hepatotoxic agent carbon tetrachloride (CCl4) thrice weekly over a period of 4 weeks or subjected to methionine-choline-deficient (MCD) diet for 8 weeks to induce liver fibrosis. Liver damage, inflammation, and fibrosis development were then assessed by biochemical methods, histology, immunostaining, flow cytometry, and quantitative realtime PCR. CCR6 and CCL20 expression was significantly up-regulated in the livers of patients with chronic liver diseases (n=50) and fibrotic murine livers. Ccl20 was strongly induced in primary murine hepatocytes upon injury. In both models of chronic liver injury, Ccr6-/- mice developed more severe fibrosis than wildtype mice. Furthermore, in CCl4-induced liver injury Ccr6-/- mice showed strongly enhanced liver inflammation compared to wt mice, as indicated by increased overall hepatic immune cell infiltration. While CCR6-deficiency did not affect the composition of hepatic T helper cell subtypes, expression of interleukin-17 (IL-17) was significantly reduced in livers of Ccr6-/- mice. Wt mice showed an accumulation of IL-17-producing gamma/delta T cells in the liver upon CCl4 treatment, which was markedly reduced in livers of Ccr6-/- mice. Concordantly, the adoptive transfer of wt gamma/delta T cells, but not of CD4+ T cells, into Ccr6-/- mice reduced hepatic inflammation and fibrosis in chronic injury, but this function was independent of their IL-17 production. Moreover, hepatic gamma/delta T cells colocalized with hepatic stellate cells (HSC) in vivo and directly inhibited HSC function by limiting their collagen synthesis and facilitating apoptosis in a Fas-dependent manner in vitro. Thus, IL-17 producing gamma/delta T cells specifically require CCR6 to migrate to the liver upon chronic injury and are able to protect the liver from excessive inflammation and fibrosis by inhibiting HSC.
Source: RWTH Publications (RWTH Aachen)
Author: Hammerich, Linda
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7055208749
